Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 28, 2015; 21(8): 2358-2366
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2358
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2358
Figure 1 Disease-free survival rates of patients in the two groups.
The 1-, 3-, 5-, and 7-year disease-free survival rates for the hepatectomy and splenectomy group were 86.7%, 70.9%, 52.7%, and 45.9%, respectively. The 1-, 3-, 5-, and 7-year disease-free survival rates for the hepatectomy alone group were 88.1%, 59.4%, 43.3%, and 39.5%, respectively (P = 0.008).
- Citation: Zhang XY, Li C, Wen TF, Yan LN, Li B, Yang JY, Wang WT, Jiang L. Synchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A case-control study. World J Gastroenterol 2015; 21(8): 2358-2366
- URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2358.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i8.2358